Allograft rejection is a widespread complication in allograft recipients with chronic kidney disease. Undertreatment of subclinical and clinical rejection and later post-transplant problems are caused by an imperfect understanding of the mechanisms at play and a lack of adequate diagnostic tools. Many different biomarkers have been analyzed and proposed to detect and monitor these crucial events in transplant outcomes. In this sense, microRNAs may help diagnose rejection or tolerance and indicate appropriate treatment, especially in patients with chronic allograft rejection. As key epigenetic regulators of physiological homeostasis, microRNAs have therapeutic potential and may indicate allograft tolerance or rejection. However, more evidence and clinical validation are indispensable before microRNAs are ready for clinical prime time.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813128PMC
http://dx.doi.org/10.3390/biomedicines12010116DOI Listing

Publication Analysis

Top Keywords

rejection tolerance
8
allograft rejection
8
rejection
6
micrornas
4
micrornas potential
4
potential graft
4
graft rejection
4
tolerance biomarkers
4
biomarkers dilemma
4
clinical
4

Similar Publications

Donor MHC-specific thymus vaccination allows for immunocompatible allotransplantation.

Cell Res

January 2025

Translational Medical Center for Stem Cell Therapy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

Organ transplantation is the last-resort option to treat organ failure. However, less than 10% of patients benefit from this only option due to lack of major histocompatibility complex (MHC)-matched donor organs and 25%-80% of donated organs could not find MHC-matched recipients. T cell allorecognition is the principal mechanism for allogeneic graft rejection.

View Article and Find Full Text PDF

This paper presents a novel adaptive fault-tolerant control (AFTC) framework for systems with piezoelectric sensor patches, specifically targeting sensor faults and external disturbances. The proposed method ensures robust control of cantilever thick plates by integrating adaptive estimation to simultaneously handle sensor faults and system uncertainties, maintaining stability despite issues like drift, bias, loss of accuracy, and effectiveness. Unlike traditional approaches that address sensor faults individually, our method provides a comprehensive solution backed by Lyapunov-based stability analysis, demonstrating uniform ultimate boundedness under various fault conditions.

View Article and Find Full Text PDF

Reduced number of regulatory T cells in maternal circulation precede idiopathic spontaneous preterm labor in a subset of patients.

Am J Obstet Gynecol

December 2024

Department of Gynecology, Obstetrics and Neonatology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address:

Background: Accumulating evidence suggests that spontaneous preterm labor is a syndrome caused by multiple pathological processes. The breakdown of maternal-fetal tolerance has been proposed as a key mechanism of idiopathic spontaneous preterm labor, often viewed as a chronic inflammatory process resulting from the maternal immune system's impaired tolerance of the fetus from early pregnancy. Regulatory T cells are crucial for maintaining maternal-fetal tolerance.

View Article and Find Full Text PDF

Targeting T helper 17 cells: emerging strategies for overcoming transplant rejection.

Clin Transplant Res

December 2024

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Solid organ transplantation has significantly improved the survival rate of patients with terminal organ failure. However, its success is often compromised by allograft rejection, a process in which T helper 17 (Th17) cells play a crucial role. These cells facilitate rejection by enhancing neutrophil infiltration into the graft and by activating endothelial cells and fibroblasts.

View Article and Find Full Text PDF

Soluble CD52 mediates immune suppression by human seminal fluid.

Front Immunol

December 2024

School of Biosciences and Bio21 Molecular Science and Biotechnology Institute, Faculty of Science, The University of Melbourne, Melbourne, VIC, Australia.

Seminal fluid provides for the carriage and nutrition of sperm, but also modulates immunity to prevent allo-rejection of sperm by the female. Immune suppression by seminal fluid has been associated with extracellular vesicles, originally termed prostasomes, which contain CD52, a glycosylated glycophosphoinositol-anchored peptide released from testicular epithelial cells. Previously, we reported that human T cell-derived CD52, bound to the danger-associated molecular pattern protein, high mobility group box 1 (HMGB1), suppresses T cell function via the inhibitory sialic acid-binding immunoglobulin-like lectin-10 (Siglec-10) receptor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!